70 related articles for article (PubMed ID: 22242438)
1. [Effects of honey to acyclovir in the rabbit eye transport kinetics].
He Q; Wang S; Zhang X; Zhang J; Jiang Y; Xu J
Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2723-6. PubMed ID: 22242438
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
3. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
Anand BS; Katragadda S; Nashed YE; Mitra AK
Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962
[TBL] [Abstract][Full Text] [Related]
4. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
5. Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits.
Chetoni P; Rossi S; Burgalassi S; Monti D; Mariotti S; Saettone MF
J Ocul Pharmacol Ther; 2004 Apr; 20(2):169-77. PubMed ID: 15117573
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
7. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
Katragadda S; Gunda S; Hariharan S; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234
[TBL] [Abstract][Full Text] [Related]
8. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
Anand B; Nashed Y; Mitra A
Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of sponge-like acyclovir ocular minitablets.
Refai H; Tag R
Drug Deliv; 2011 Jan; 18(1):38-45. PubMed ID: 20804440
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis.
Wu X; Chen X
Chin Med J (Engl); 2002 Oct; 115(10):1569-72. PubMed ID: 12490113
[TBL] [Abstract][Full Text] [Related]
11. Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy.
Castela N; Vermerie N; Chast F; Sauvageon-Martre H; Denis J; Godard V; Goldschmidt P; Pouliquen Y
J Ocul Pharmacol; 1994; 10(2):439-51. PubMed ID: 8083563
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis.
Wang X; Wang L; Wu N; Ma X; Xu J
Chin Med J (Engl); 2015 Jan; 128(1):46-50. PubMed ID: 25563312
[TBL] [Abstract][Full Text] [Related]
13. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
[TBL] [Abstract][Full Text] [Related]
14. Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits.
Stella B; Arpicco S; Rocco F; Burgalassi S; Nicosia N; Tampucci S; Chetoni P; Cattel L
Eur J Pharm Biopharm; 2012 Jan; 80(1):39-45. PubMed ID: 22008147
[TBL] [Abstract][Full Text] [Related]
15. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique.
Hughes PM; Krishnamoorthy R; Mitra AK
J Ocul Pharmacol Ther; 1996; 12(2):209-24. PubMed ID: 8773936
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of acyclovir in rabbit skin after i.v.-bolus, ointment, and iontophoretic administrations.
Stagni G; Ali ME; Weng D
Int J Pharm; 2004 Apr; 274(1-2):201-11. PubMed ID: 15072796
[TBL] [Abstract][Full Text] [Related]
17. [Ocular pharmacokinetics and bioavailability of 0.2% ganciclovir in-situ gelling eye drops].
Zhang JJ; Gao CF; Wang LY
Zhonghua Yan Ke Za Zhi; 2006 Jul; 42(7):637-41. PubMed ID: 17081425
[TBL] [Abstract][Full Text] [Related]
18. Design of xanthone propionate photolabile protecting group releasing acyclovir for the treatment of ocular herpes simplex virus.
Blake JA; Bareiss B; Jimenez L; Griffith M; Scaiano JC
Photochem Photobiol Sci; 2012 Mar; 11(3):539-47. PubMed ID: 22222893
[TBL] [Abstract][Full Text] [Related]
19. An experimental study of a new route for Acyclovir administration for anti-keratitis therapeutic treatment.
Wang B; Teng W; Han X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):379-81. PubMed ID: 11471033
[TBL] [Abstract][Full Text] [Related]
20. Intraocular penetration of topically administered acyclovir.
Kitagawa K; Fukuda M; Sasaki K
Lens Eye Toxic Res; 1989; 6(1-2):365-73. PubMed ID: 2488028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
